Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancer

by Keitaro Watanabe, Takeo Kosaka, Hiroshi Hongo, Mototsugu Oya
Published 2021

Topoisomerase II alpha inhibition can overcome taxane-resistant prostate cancer through DNA repair pathways

by Hiroshi Hongo, Takeo Kosaka, Yoko Suzuki, Shuji Mikami, Junichi Fukada, Mototsugu Oya
Published 2021

Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer

by Ken-ichi Takayama, Takeo Kosaka, Takashi Suzuki, Hiroshi Hongo, Mototsugu Oya, Tetsuya Fujimura, Yutaka Suzuki, Satoshi Inoue
Published 2021

CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer

by Yoshinori Yanai, Takeo Kosaka, Shuji Mikami, Hiroshi Hongo, Yota Yasumizu, Toshikazu Takeda, Kazuhiro Matsumoto, Jun Miyauchi, Shigehisa Kitano, Mototsugu Oya
Published 2021